Featured Research

from universities, journals, and other organizations

Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography

Date:
July 21, 2010
Source:
American College of Radiology / American Roentgen Ray Society
Summary:
A recent questionnaire submitted to a group of patients at one of the nation's largest general hospitals suggests that a significant number of patients, who have previously refused colorectal cancer screening, are willing to undergo computed tomography colonography, but not willing to pay for the exam themselves when not covered by insurance, according to a study.

A recent questionnaire submitted to a group of patients at one of the nation's largest general hospitals suggests that a significant number of patients, who have previously refused colorectal cancer screening, are willing to undergo computed tomography colonography (CTC) (or virtual colonoscopy), but not willing to pay for the exam themselves when not covered by insurance, according to a study in the August issue of the American Journal of Roentgenology.

Noninvasive CTC is increasingly being considered for colorectal cancer screening. It uses CT imaging and computers to produce 2D and 3D images of the colon. Compared to conventional colonoscopies, CTC does not require sedation.

The study, performed at Massachusetts General Hospital in Boston, MA, included 68 patients who had been offered colorectal cancer screening. Patients participated in a questionnaire and were asked about their willingness to undergo CTC and about other relevant factors, such as fees. Patient's reasons for not being screened were also explored.

"After being informed about CTC screening, most (83 percent) subjects stated they would be willing to undergo a CTC study," said Chin Hur, MD, lead author of the study. "However, 70 percent stated they would not be willing to pay out-of-pocket fees if insurance did not cover the study, and even among the 30 percent who were willing to pay the fees, the average amount they were willing to pay (mean, $244; median, $150) was well below currently charged rates," said Hur.

"After being informed about CTC as a screening technique for colorectal cancer, the majority of currently nonadherent patients stated that they would be willing to have a CTC screening study, suggesting that CTC availability could improve screening rates," he said.

"However, the majority of participants were not willing to pay out-of-pocket expenses, and even among those who were willing, most were not willing to pay currently charged fees," said Hur. The currently charged rate is between $500 and $1500.


Story Source:

The above story is based on materials provided by American College of Radiology / American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American College of Radiology / American Roentgen Ray Society. "Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography." ScienceDaily. ScienceDaily, 21 July 2010. <www.sciencedaily.com/releases/2010/07/100721133223.htm>.
American College of Radiology / American Roentgen Ray Society. (2010, July 21). Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/07/100721133223.htm
American College of Radiology / American Roentgen Ray Society. "Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography." ScienceDaily. www.sciencedaily.com/releases/2010/07/100721133223.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins